VR
AMGN icon

Viridian RIA’s Amgen AMGN Stock Holding History

Viridian RIA’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$313K Buy
1,294
+1
+0.1% +$230 0.07% 75
2021
Q4 		$291K Hold
1,293
– – 0.06% 81
2021
Q3 		$425 Buy
1,293
+1
+0.1% +$230 0.1% 11
2021
Q2 		$315K Buy
1,292
+1
+0.1% +$246 0.07% 73
2021
Q1 		$321K Buy
1,291
+1
+0.1% +$239 0.08% 68
2020
Q4 		$297K Buy
1,290
+1
+0.1% +$231 0.08% 61
2020
Q3 		$328K Sell
1,289
-282
-18% -$69.9K 0.11% 56
2020
Q2 		$370K Buy
1,571
+473
+43% +$108K 0.13% 53
2020
Q1 		$223K Hold
1,098
– – 0.1% 53
2019
Q4 		$265K Hold
1,098
– – 0.09% 54
2019
Q3 		$212K Hold
1,098
– – 0.09% 56
2019
Q2 		$202K Sell
1,098
-50
-4% -$8.95K 0.08% 57
2019
Q1 		$218K Hold
1,148
– – 0.1% 50
2018
Q4 		$224K Sell
1,148
-386
-25% -$75.3K 0.11% 52
2018
Q3 		$317K Sell
1,534
-168
-10% -$33.1K 0.14% 48
2018
Q2 		$333K Hold
1,702
– – 0.16% 37
2018
Q1 		$298K Buy
+1,702
New +$312K 0.14% 41

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Viridian RIA's AMGN Position: Q1 2022 in Review

Viridian RIA increased its Amgen (AMGN) stake by 0.08% in Q1 2022, buying an estimated $230 and bringing the position to 1,294 shares worth $313K. The position accounts for 0.07% of the portfolio, ranked #75.

Viridian RIA first reported a position in AMGN in Q1 2018 and has held it in 17 quarters since. The position peaked at $370K in Q2 2020. 2,338 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.

  • Viridian RIA held 1,294 shares of Amgen worth $313K as of Q1 2022.
  • Viridian RIA bought 1 Amgen share in Q1 2022, an estimated $230.
  • Amgen made up 0.07% of Viridian RIA's portfolio in Q1 2022, its #75 holding.
  • Viridian RIA first reported a position in Amgen in Q1 2018 and has held it in 17 quarters since.
  • Viridian RIA's Amgen position peaked at $370K in Q2 2020.
  • 2,338 funds tracked by Wall St. Rank held Amgen as of Q1 2022.

Based on Viridian RIA's 13F filing for Q1 2022, filed 26 Apr 2022.